Citation: Bd. Reilly, SUBSTITUTION OF THE C4A (1101)PROLINE WITH THE C4B (1101)LEUCINE DECREASES THE APPARENT AVIDITY OF C4A FOR CR-1, Molecular immunology, 35(6-7), 1998, pp. 263-263
Citation: Bd. Reilly et C. Mold, QUANTITATIVE-ANALYSIS C4AB AND C4BB BINDING TO THE C3B C4B RECEPTOR (CR-1, CD35)/, Clinical and experimental immunology, 110(2), 1997, pp. 310-316
Citation: Bd. Reilly et al., EVIDENCE SHOWING THAT THE 1105-ISOTYPIC AND 1106-ISOTYPIC RESIDUES OFTHE FOURTH COMPONENT OF HUMAN-COMPLEMENT, C4A, ARE NOT INVOLVED IN AMIDE BOND FORMATION, Molecular immunology, 31(10), 1994, pp. 761-769
Authors:
REILLY BD
MAKRIDES SC
FORD PJ
MARSH HC
MOLD C
Citation: Bd. Reilly et al., QUANTITATIVE-ANALYSIS OF C4B DIMER BINDING TO DISTINCT SITES ON THE C3B C4B RECEPTOR (CR-1)/, The Journal of biological chemistry, 269(10), 1994, pp. 7696-7701
Authors:
REILLY BD
MAKRIDES SC
FORD PJ
MARSH HC
MOLD C
Citation: Bd. Reilly et al., IDENTIFICATION OF THE C4B BINDING-SITES IN CR-1 USING RECOMBINANT FORMS OF CR-1, The Journal of immunology, 150(8), 1993, pp. 224-224
Citation: D. Otero et al., COMPARISON OF COMPLEMENT ACTIVATION BY IGG AND C-REACTIVE PROTEIN (CRP) IMMUNE-COMPLEXES, The Journal of immunology, 150(8), 1993, pp. 226-226